A study found that the oral antiviral medicine molnupiravir cut hospitalization risk by half.
— Read on www.everydayhealth.com/coronavirus/merck-seeks-fda-authorization-for-first-covid-pill/
A study found that the oral antiviral medicine molnupiravir cut hospitalization risk by half.
— Read on www.everydayhealth.com/coronavirus/merck-seeks-fda-authorization-for-first-covid-pill/